Skip to Content

Cyclosporine Injection

Last Updated: August 21, 2014
Status: Resolved

Products Affected - Description

Cyclosporine 50 mg/mL solution for injection, West-Ward (formerly Bedford product)
5 mL vial, 10 count (NDC 55390-0122-10)

Reason for the Shortage

  • Perrigo acquired Paddock Laboratories in July 2011. Perrigo discontinued cyclosporine injection in late-November, 2011.
  • West-Ward Pharmaceuticals’ parent company, Hikma Pharmaceuticals, acquired cyclosporine injection from Bedford in July 2014. West-Ward is not actively marketing cyclosporine injection.

Available Products

Sandimmune 50 mg/mL solution for injection, Novartis
5 mL ampule, 10 count (NDC 00078-0109-01)

Estimated Resupply Dates

West-Ward is not actively marketing cyclosporine injection.

Related Shortages

Updated

August 21, 2014; May 12, 2014; February 14, 2014; November 15, 2013; September 16, 2013; August 5, 2013; June 27, 2013; May 30, 2013; March 29, 2013; January 30, 2013; November 12, 2012; September 19, 2012; August 1, 2012; June 18, 2012; June 5, 2012; May 1, 2012; March 20, 2012; February 8, 2012; January 4, 2012; December 6, 2011; November 21, 2011; October 26, 2011; September 20, 2011; June 7, 2010; June 2, 2010; May 24, 2010; April 30, 2010; April 5, 2010; March 16, 2010; March 1, 2010; February 5, 2010; January 12, 2009; December 15, 2008; December 1, 2008; November 3, 2008; October 15, 2008; September 9, 2008; August 18, 2008, University of Utah, Drug Information Service. Copyright 2014, University of Utah, Drug Information Service.

Hide